Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
B3GNTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNORA70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOCS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZDHHC14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF83 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ASMTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Homologene neighbors
MIR4321 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01424 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPCN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBSCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6727 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on